Characteristics of Patients With Strongly Hormone Receptor–Positive and Human Epidermal Growth Factor Receptor 2–Negative Invasive Ductal Carcinoma Receiving NACT or NET, After Propensity Score Matching. Here, ERBB2 is linked to breast ductal adenocarcinoma.